These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23133627)
21. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell. Xu L; Wang C; Wen Z; Yao X; Liu Z; Li Q; Wu Z; Xu Z; Liang Y; Ren T Immunol Lett; 2010 Jan; 127(2):93-9. PubMed ID: 19854217 [TBL] [Abstract][Full Text] [Related]
22. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma. Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900 [TBL] [Abstract][Full Text] [Related]
23. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles. Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219 [TBL] [Abstract][Full Text] [Related]
24. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5. Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430 [TBL] [Abstract][Full Text] [Related]
25. MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer. Wang Z; Liu Z; Fang X; Yang H Cell Physiol Biochem; 2017; 43(6):2505-2515. PubMed ID: 29131028 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-219-5p Inhibits Morphine-Induced Apoptosis by Targeting Key Cell Cycle Regulator WEE1. Lou W; Zhang X; Hu XY; Hu AR Med Sci Monit; 2016 Jun; 22():1872-9. PubMed ID: 27253431 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway. Bai X; Shao J; Zhou S; Zhao Z; Li F; Xiang R; Zhao AZ; Pan J J Exp Clin Cancer Res; 2019 Nov; 38(1):479. PubMed ID: 31783879 [TBL] [Abstract][Full Text] [Related]
28. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124. Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749 [TBL] [Abstract][Full Text] [Related]
29. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer. Jin X; Guan Y; Zhang Z; Wang H BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382 [TBL] [Abstract][Full Text] [Related]
30. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. Zhang Y; Jiang WL; Yang JY; Huang J; Kang G; Hu HB; Xie S J Cell Physiol; 2019 Aug; 234(10):18679-18687. PubMed ID: 30993701 [TBL] [Abstract][Full Text] [Related]
32. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles]. Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846 [TBL] [Abstract][Full Text] [Related]
33. CircFOXP1/FOXP1 promotes osteogenic differentiation in adipose-derived mesenchymal stem cells and bone regeneration in osteoporosis via miR-33a-5p. Shen W; Sun B; Zhou C; Ming W; Zhang S; Wu X J Cell Mol Med; 2020 Nov; 24(21):12513-12524. PubMed ID: 32996692 [TBL] [Abstract][Full Text] [Related]
34. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation. Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723 [TBL] [Abstract][Full Text] [Related]
35. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1. Gan CZ; Li G; Luo QS; Li HM IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895 [TBL] [Abstract][Full Text] [Related]
36. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling. Zhu Y; Zhang X; Qi M; Zhang Y; Ding F J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290 [TBL] [Abstract][Full Text] [Related]
37. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip. Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958 [TBL] [Abstract][Full Text] [Related]
38. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells. Ba Z; Zhou Y; Yang Z; Xu J; Zhang X J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188 [TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
40. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Lu YJ; Liu RY; Hu K; Wang Y Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]